First Time Loading...

Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 36 GBX Market Closed
Updated: May 1, 2024

Creo Medical Group PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Creo Medical Group PLC
Operating Income Peer Comparison

Comparables:
SN
LIVN
LMDX
EKF
AGL

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Creo Medical Group PLC
LSE:CREO
Operating Income
-£30.8m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Operating Income
$763m
CAGR 3-Years
14%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Operating Income
$57m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
N/A
LumiraDx Ltd
NASDAQ:LMDX
Operating Income
-$225.1m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Operating Income
£4.9m
CAGR 3-Years
-32%
CAGR 5-Years
-3%
CAGR 10-Years
7%
Angle PLC
LSE:AGL
Operating Income
-£24.5m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Creo Medical Group PLC's Operating Income?
Operating Income
-30.8m GBP

Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Operating Income amounts to -30.8m GBP.

What is Creo Medical Group PLC's Operating Income growth rate?
Operating Income CAGR 3Y
-18%

Over the last year, the Operating Income growth was -3%. The average annual Operating Income growth rates for Creo Medical Group PLC have been -18% over the past three years .